isabelobrien, Author at European Medical Journal - Page 23 of 29

Talking to Dario Safaric

Dario Safaric, Chairman of the NEXT Pharma Summit, shares his journey of starting a conference from scratch, Croatia’s historical relationship with the pharmaceutical industry, and the future outlook for medical conferences in the post-COVID-19 era.

Talking to Nigel Adkins

Nigel Adkins, professional football manager, former player, and physiotherapist, talks about his career in football, the valuable lessons he has learnt about leadership, and the importance of routine in navigating challenging professional periods.

Talking to Dr John Michels

Dr John Michels, former NFL player turned renowned interventional pain specialist, explores the mindset it takes to become successful, how to be the master of your own outcomes and the science behind negative habit cycles and how to beat them.

Talking to Steve Ingham

Steve Ingham, leading performance scientist and founder of the performance consultancy, Supporting Champions, talks about his work with the British Olympic team, how to earn the respect of high performers, and what businesses can learn from the mindsets of professional athletes.

Talking to Mircea Cubillos

Mircea Cubillos, Vice President Hematology EMEA, Commercial Strategy Lead, Janssen, discusses his lengthy career at Janssen, progression in oncology during COVID-19, and cultivating healthy habits during lockdown.

Talking to Will Champion

Will Champion, drummer for the band Coldplay, discusses the mindset it takes to become and remain successful, as well as how to cultivate effective collaboration and sustain passion and creativity over long stretches of time.

Chief Digital Officers: the pioneers of cultural change

Meet the Chief Digital Officer: a person that ensures a pharmaceutical company evolves with the times through continued collaboration and culture shifts.

The metrics of medical affairs

Measuring the impact of medical affairs is less straightforward than it is for R&D or commercial, but we must establish success metrics.

Creating brand loyalty with RWE

The commercial value of RWE is yet to be realised, but the benefits extend far beyond the aisles in which it is currently in high demand.

Calling checkmate on meaningless social media

The pharma industry is dabbling in the game of social media, and it’s no secret that they need to have a better presence on these platforms.